IWG (LON:IWG – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Jefferies Financial Group in a research note issued to investors on Tuesday, Digital Look reports. They presently have a GBX 235 price target on the stock. Jefferies Financial Group‘s price objective points to a potential upside of 13.86% from the company’s current price.
A number of other brokerages also recently issued reports on IWG. Royal Bank Of Canada reiterated an “outperform” rating and issued a GBX 260 price objective on shares of IWG in a research report on Wednesday, August 12th. Berenberg Bank restated a “buy” rating and set a GBX 350 target price on shares of IWG in a research report on Tuesday. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 263.80.
Get Our Latest Research Report on IWG
IWG Stock Up 4.6%
Insider Buying and Selling at IWG
In related news, insider Christian Schmitz acquired 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The shares were bought at an average cost of GBX 183 per share, for a total transaction of £91,500. Insiders have purchased 125,000 shares of company stock valued at $22,050,000 in the last quarter. 26.19% of the stock is currently owned by corporate insiders.
IWG Company Profile
IWG plc, together with its subsidiaries, provides workspace solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers office, coworking and collaboration, flexible and scalable, meeting, and lounges spaces; workplace recovery; memberships workspaces; and reception services and conference products. It provides its services franchise partners, landlords, and property owners under the Regus, Spaces, HQ, Signature, Basepoint, Stop & Work, The Office Operators, BizDojo, Open Office, No18, The Clubhouse, Central Working, and Copernico brands.
Featured Stories
- Five stocks we like better than IWG
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for IWG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IWG and related companies with MarketBeat.com's FREE daily email newsletter.
